Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v1-EN
Language French English
Date Updated 2022-09-21 2022-05-18
Drug Identification Number 02267667 02267667
Brand name RABAVERT RABAVERT
Common or Proper name Rabies vaccine Rabies vaccine
Company Name BAVARIAN NORDIC AS BAVARIAN NORDIC AS
Ingredients RABIES VACCINE INACTIVATED RABIES VACCINE INACTIVATED
Strength(s) 2.5UNIT 2.5UNIT
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 pack 1 pack
ATC code J07BG J07BG
ATC description VIRAL VACCINES VIRAL VACCINES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2022-05-18 2022-05-18
Actual start date 2022-05-18 2022-05-18
Estimated end date 2022-08-30 2022-08-30
Actual end date 2022-09-20
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Supply available for public programs. Supply unavailable for the private market. For emergency supply, contact Valneva Customer Service 1-855-385-6725 or csrvalneva@accuristix.com Supply available for Public programs. Supply unavailable for the private market. For emergency supply, contact Valneva Customer Service 1-855-385-6725 or csrvalneva@accuristix.com
Health Canada comments